• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.

作者信息

Jani Ashesh B, Ravizzini Gregory C, Gartrell Benjamin A, Siegel Barry A, Twardowski Przemyslaw, Saltzstein Daniel, Fleming Mark T, Chau Albert, Davis Phillip, Chapin Brian F, Schuster David M

机构信息

Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.

Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

出版信息

J Urol. 2023 Sep;210(3):411-412. doi: 10.1097/JU.0000000000003598. Epub 2023 Jun 23.

DOI:10.1097/JU.0000000000003598
PMID:37350185
Abstract
摘要

相似文献

1
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.F-rhPSMA-7.3正电子发射断层扫描在疑似前列腺癌复发男性中的诊断性能和安全性：一项3期前瞻性多中心研究（SPOTLIGHT）的结果。回复
J Urol. 2023 Sep;210(3):411-412. doi: 10.1097/JU.0000000000003598. Epub 2023 Jun 23.
2
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Letter.F-rhPSMA-7.3正电子发射断层扫描在疑似前列腺癌复发男性中的诊断性能与安全性：一项3期前瞻性多中心研究（SPOTLIGHT）的结果。信函
J Urol. 2023 Sep;210(3):410-411. doi: 10.1097/JU.0000000000003597. Epub 2023 Jun 22.
3
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).F-rhPSMA-7.3正电子发射断层扫描在疑似前列腺癌复发男性中的诊断性能和安全性：一项3期前瞻性多中心研究（SPOTLIGHT）的结果
J Urol. 2023 Aug;210(2):299-311. doi: 10.1097/JU.0000000000003493. Epub 2023 Apr 26.
4
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.18F-氟丁醇正电子发射断层扫描对前列腺癌生化复发治疗的影响：LOCATE 试验结果。
J Urol. 2019 Feb;201(2):322-331. doi: 10.1016/j.juro.2018.08.050.
5
Uptake of F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study.前列腺癌正电子发射断层扫描成像中 F-rhPSMA-7.3 的摄取：一项 I 期概念验证研究。
Cancer Biother Radiopharm. 2022 Apr;37(3):205-213. doi: 10.1089/cbr.2021.0322. Epub 2021 Dec 28.
6
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with F-DCFPyL in Prostate Cancer Patients (OSPREY).前列腺特异性膜抗原 PET/CT 联合 F-DCFPyL 对前列腺癌患者的诊断准确性的 2/3 期前瞻性多中心研究（OSPREY）。
J Urol. 2021 Jul;206(1):52-61. doi: 10.1097/JU.0000000000001698. Epub 2021 Feb 26.
7
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.前列腺特异性膜抗原示踪剂在前列腺癌生化复发中的正电子发射断层扫描/计算机断层扫描检测率：系统评价和网络荟萃分析。
J Urol. 2021 Feb;205(2):356-369. doi: 10.1097/JU.0000000000001369. Epub 2020 Sep 16.
8
F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study.F-rhPSMA-7 PET 用于检测根治性放疗后前列腺癌的生化复发：一项双中心回顾性研究。
J Nucl Med. 2022 Aug;63(8):1208-1214. doi: 10.2967/jnumed.121.262861. Epub 2022 Mar 10.
9
Patterns of Prostate Cancer Recurrence After Brachytherapy Determined by Prostate-Specific Membrane Antigen-Positron Emission Tomography and Computed Tomography Imaging.通过前列腺特异性膜抗原-正电子发射断层扫描和计算机断层扫描成像确定的近距离放射治疗后前列腺癌复发模式
Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1126-1134. doi: 10.1016/j.ijrobp.2021.12.164. Epub 2022 Jan 2.
10
Validation of F-rhPSMA-7 and F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer.F-rhPSMA-7 和 F-rhPSMA-7.3 PET 成像结果与前列腺癌生化复发患者挽救性手术中组织病理学的验证。
J Nucl Med. 2022 Dec;63(12):1809-1814. doi: 10.2967/jnumed.121.263707. Epub 2022 Apr 7.

引用本文的文献

1
Positron Emission Tomography Radiotracers for Identification of Site of Recurrence in Prostate Cancer After Primary Treatment Failure.用于识别前列腺癌初次治疗失败后复发部位的正电子发射断层显像放射性示踪剂
Cancers (Basel). 2025 May 21;17(10):1723. doi: 10.3390/cancers17101723.
2
Safety, Dosimetry, and Feasibility of [Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer.[镓]Ga-PSMA-R2作为生化复发或转移性前列腺癌患者成像剂的安全性、剂量学及可行性
J Nucl Med. 2025 Mar 3;66(3):359-365. doi: 10.2967/jnumed.124.268318.
3
Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning.
在前列腺特异性膜抗原（PSMA）扫描分期中区分生理性输尿管摄取与受累淋巴结：对放射治疗计划的影响。
Cureus. 2024 Jun 25;16(6):e63105. doi: 10.7759/cureus.63105. eCollection 2024 Jun.
4
PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?PSMA 靶向放射性核素治疗在现代核医学中的应用：过去、现在和未来？
Theranostics. 2024 May 13;14(8):3043-3079. doi: 10.7150/thno.92612. eCollection 2024.
5
Preclinical comparison of [Lu]Lu-rhPSMA-10.1 and [Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies.[镥]镥-rhPSMA-10.1和[镥]镥-rhPSMA-10.2用于前列腺癌内放射治疗的临床前比较：生物分布和剂量学研究。
EJNMMI Radiopharm Chem. 2024 Feb 26;9(1):18. doi: 10.1186/s41181-024-00246-2.
6
Prostate Cancer Skeletal Metastasis: A Spontaneous Evolution from Osteolytic to Osteoblastic Morphology without Treatment.前列腺癌骨转移：未经治疗情况下从溶骨性到成骨性形态的自然演变
World J Nucl Med. 2023 Dec 26;22(4):316-320. doi: 10.1055/s-0043-1777697. eCollection 2023 Dec.
7
PSMA PET imaging in the diagnosis and management of prostate cancer.PSMA PET 成像在前列腺癌的诊断和治疗中的应用。
Abdom Radiol (NY). 2023 Dec;48(12):3610-3623. doi: 10.1007/s00261-023-04002-z. Epub 2023 Jul 26.